Menopause Hormone Therapy (HRT) in Reno, NV

Bioidentical hormones in Reno: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

For women in Reno, a physician licensed in Nevada can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

For its size, Reno is well supplied with OB-GYNs: the NPI registry lists 86, or 32.0 per 100,000 residents, against 17.8 for the US and above Nevada's 13.8. With about 30,648 women aged 45 to 64 living in Reno, that is about 360 for each OB-GYN in the city, before counting any younger patients.

Widen the circle and the count grows: 86 in the city or within 10 miles, 95 within 25 miles. For the 537,882 people who live within 25 miles, that is 17.7 per 100,000. None of this replaces your own OB-GYN or a menopause doctor you trust; VevaMD adds an online route, with a physician licensed in Nevada reviewing your answers from home in Reno.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG recommends FDA-approved menopause hormone therapy over compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11